Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nephrol Dial Transplant
Autores principales: Airy, Medha, Mandayam, Sreedhar, Mitani, Aya A., Chang, Tara I., Ding, Victoria Y., Brookhart, M. Alan, Goldstein, Benjamin A., Winkelmayer, Wolfgang C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2015
Materias:
Clinical Science
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829057/
https://ncbi.nlm.nih.gov/pubmed/26311216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv305
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares